Long-Term Use and Cost-Effectiveness of Secondary Prevention Medications for Heart Disease in Western Australian Seniors

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1066242

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Clinical trials show that long-term treatment with selected medicines greatly reduces the risk of further heart attacks or stroke in persons with known heart disease. Levels of such prescribing is high when patients are discharged from hospital, but the extent to which patients continue with long-term treatment is unknown. We will investigate compliance with treatment, and the costs and effectiveness of these medicines in a population study of patients aged 65 years or more in Western Australia.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $760,525.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adherence | cardiovascular disease prevention | coronary heart disease (CHD) | cost-effectiveness | outcomes research | pharmacoepidemiology | population-based | prescribing | record linkage

Related Links